Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
15 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06296056 | Phase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi)(SDH-Combi) | completed | Phase 1 | 9 | Seoul HospitalOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT06137950 | Interferon Alpha Therapy for Cervical CINI and HPV Infection | completed | Phase 1 | 60 | Mongolian National University of Medical SciencesOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT05852002 | A Clinical Study of Pain and Discomfort Associated With Advanced Lung Cancer | completed | N/A | 10 | Nakhia Impex LLCINDUSTRY | 1 | Jan 17, 2024 | clinicaltrials |
| NCT00860886 | Premenopausal Hormone Concentrations in a Population of Women at Very Low Risk of Breast Cancer | completed | — | 412 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2020 | clinicaltrials |
| NCT01160549 | Study of Pregnancy Hormone Concentrations in Urban and Nomadic Mongolian Women | completed | — | 412 | National Cancer Institute (NCI)NIH | 1 | Mar 16, 2020 | clinicaltrials |
| NCT02256514 | Open Label Trial of Immunotherapy for Advanced Liver Cancer(HCC) | unknown | Phase 2 | 120 | Immunitor LLCINDUSTRY | 1 | Aug 30, 2019 | clinicaltrials |
| NCT03042182 | Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma(cholangio) | unknown | Phase 1 / Phase 2 | 20 | Immunitor LLCINDUSTRY | 1 | Aug 30, 2019 | clinicaltrials |
| NCT03165591 | Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer(V3-P) | unknown | Phase 1 / Phase 2 | 30 | Immunitor LLCINDUSTRY | 1 | Aug 30, 2019 | clinicaltrials |
| NCT03550755 | Immunotherapy of Cervical Cancer With V3-Cervix(V3-Cervix) | unknown | Phase 2 | 20 | Immunitor LLCINDUSTRY | 1 | Aug 30, 2019 | clinicaltrials |
| NCT03556566 | Open Label Immunotherapy Trial for Ovarian Cancer(V3-OVA) | unknown | Phase 2 | 20 | Immunitor LLCINDUSTRY | 1 | Aug 30, 2019 | clinicaltrials |
| NCT03572361 | Open Label Immunotherapy Trial for Breast Cancer(V3-MOMMO) | unknown | Phase 2 | 20 | Immunitor LLCINDUSTRY | 1 | Aug 30, 2019 | clinicaltrials |
| NCT03916757 | V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer(GBM) | unknown | Phase 2 | 20 | Immunitor LLCINDUSTRY | 1 | Apr 17, 2019 | clinicaltrials |
| NCT02232490 | Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L(Hepko-V5) | unknown | Phase 3 | 120 | Immunitor LLCINDUSTRY | 1 | Feb 26, 2019 | clinicaltrials |
| NCT03550703 | Open Label Immunotherapy of Myoma(V3-myoma) | unknown | Phase 2 | 30 | Immunitor LLCINDUSTRY | 1 | Jul 6, 2018 | clinicaltrials |
| NCT01135056 | Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)(SIRveNIB) | unknown | Phase 3 | 360 | Singapore General HospitalOTHER | 12 | Apr 24, 2018 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials